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Abstract
SWAP-70, a phosphatidylinositol trisphosphate (PtdIns(3,4,5)P3) binding protein, has been suggested to be involved in
transformation of mouse embryo fibroblasts (MEFs) as well as membrane ruffling after growth factor stimulation of the cells.
A mutant, SWAP-70-374, was found to be able to bind to F-actin in vitro, whereas wild-type SWAP-70 failed to do so. This
mutant was present at the plasma membrane without any stimulation while the wild-type protein was present only in the
cytosol unless cells were stimulated with EGF. Expression of this mutant in MEFs resulted in morphologic transformation,
fast growth, and loss of contact inhibition, suggesting that SWAP-70 with this mutation can transform the cells. ERK1/2 was
activated in SWAP-70-374-transformed cells. Use of MEK inhibitors revealed that the ERK1/2 pathway does not affect the cell
growth of MEFs but is responsible for loss of contact inhibition. To investigate the function of SWAP-70 further, drugs that
can inhibit SWAP-70-dependent cell responses were screened. Among various drugs, sanguinarine was found to inhibit
transformation of MEFs by SWAP-70-374. This drug was able to inhibit SWAP-70-mediated membrane ruffling as well,
suggesting that its effect was closely related to the SWAP-70 signaling pathway. These results suggest that SWAP-70-374
can activate some signaling pathways, including the ERK1/2 pathway, to transform MEFs.
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Introduction
SWAP-70 is a phosphatidylinositol trisphosphate (PtdIns(3,4,5)
P3) binding protein, that has been implicated to play a role in the
formation of cancer. Strong expression of SWAP-70 is often seen
in human B-cell neoplasms [1]. SWAP-70 has been also shown to
be expressed in higher levels in malignant gliomas than in low-
grade ones or normal brain tissue [2]. These results suggest that
SWAP-70 may be closely related to formation of malignant tumors
in vivo. Involvement of SWAP-70 in transformation of the cells has
also been suggested in vitro. We have shown that SWAP-70 is
required for the anchorage-independent growth of v-Src-trans-
formed MEFs [3]. In addition, growth of the cells lacking SWAP-
70 has been shown to be slower than that of the cells expressing
SWAP-70 [3]. These results suggest that SWAP-70 may be
involved in regulation of cell growth in some way. It has been
suggested that SWAP-70 is important for cell motility and invasion
of the tumor cells [2,4].
Although how SWAP-70 contributes to the formation of cancers
is largely unknown, some of SWAP-70’s activities at the
biochemical or cell biological level have been revealed. SWAP-
70 contains a pleckstrin homology (PH) domain, which is
responsible for PtdIns(3,4,5)P3 binding, in the central part and a
coiled-coil domain in the carboxyl-terminal half [5,6]. In addition,
carboxyl-terminal region of SWAP-70 has been shown to bind to
non-muscle F-actin in vitro [7]. One of the well-studied cell
responses related to actin rearrangement is membrane ruffling,
which is closely related to cell motility. SWAP-70 translocates from
the cytoplasm to the membrane ruffles upon PtdIns 3-kinase
activation after growth factor stimulation and co-localizes with F-
actin in adherent cells such as MEF or Cos7. Cells lacking SWAP-
70 show impaired membrane ruffling after growth factor
stimulation, suggesting that SWAP-70 may play a crucial role in
induction of membrane ruffling [5]. SWAP-70 lacking the F-actin
binding domain has been shown to act as a dominant negative
reagent for membrane ruffling, suggesting that this actin-binding
activity is important for membrane ruffling [7]. Binding of SWAP-
70 to activated Rac1, which has been shown to regulate actin
rearrangement including membrane ruffling, has been also
detected [7]. Taken together with the fact that SWAP-70 binds
to PtdIns(3,4,5)P3, a product of PtdIns 3-kinase, that has been also
suggested to be essential for membrane ruffling, it is likely that
SWAP-70 is an important molecule that may put the functions of
PtdIns(3,4,5)P3, F-actin, and Rac1 together. Supporting these
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homing of B cells to lymphoid organs, which may require F-actin
rearrangement [8]. Because F-actin rearrangement is likely to be
related to cell transformation, these findings support the idea that
SWAP-70 contributes to tumor formation in some way.
Sanguinarine, a benzophenanthridine alkaloid, has been shown
to exhibit anti-cancer activity in vivo and in vitro
[9,10,11,12,13,14,15]. For instance, sanguinarine exhibits anti-
proliferative and antiangiogenic effects in melanoma and preven-
tion activity of occurrence of skin cancers. There are also a
number of reports suggesting that sanguinarine inhibits growth of
tumor cell lines and induces apoptosis. Recently, it has been
suggested that sanguinarine interacts with DNA and histones,
which might be the mechanism for its anti-tumor activity [16].
However, this does not completely explain the fact that
sanguinarine is effective only for certain tumor cell lines.
In this paper, we demonstrate that a mutant of SWAP-70 can
transform mouse embryo fibroblast and further suggest that an
anti-cancer drug, sanguinarine inhibits SWAP-70-dependent cell
responses.
Materials and Methods
Cells and culture conditions
Mouse embryo fibroblasts (MEFs) were cultured from a 129/
SvEMS strain in Dulbecco’s modified minimal essential medium
(DMEM) supplemented with 10% fetal bovine serum. The culture
was maintained carefully and established as an immortalized cell
line: this was named as MEF clone 18. However, MEFs are usually
mixtures of cells derived from various origins: thus cells can give
various phenotypical backgrounds. For this reason, when cell lines
expressing some gene are produced, each line could have a
different background. To deal with this problem, cells were
isolated by limiting dilution method and grown from single cells.
One of these cells, 18-2, was used in this study [3]. In this way,
phenotypic background should be identical among the clones. 70-
5 is a MEF cell line that expresses wild-type SWAP-70 [3].
Cos7 cells were cultured in DMEM supplemented with 5% calf
serum and mutant SWAP-70 genes cloned into pEGFP-C1
(Clontech Inc., Madison, WI), an expression vector, were
introduced into these cells by electroporation [17].
Establishment of cell lines carrying the exogenous
SWAP-70 genes
To obtain MEF clones expressing human mutant SWAP-70s,
an expression vector pMIKHyg harboring wild-type or mutant
SWAP-70 was used. As has been described previously, pMIKHyg,
an expression vector, contains the hygromycin-resistant gene
instead of the G418-resistant gene in pMIKNeo, which has been
described before [3]. SWAP-70-374 carries two point mutations
K374A/K375A, which was introduced using a primer, 59-
gcagcagaagaggaagcggcgcgccttcagactcaa-39, by the method de-
scribed by Sawano et al. [18]. SWAP-70-374m1 carries additional
mutations within the PH domain of SWAP-70, K219A/K220A,
which abolish the binding activity of SWAP-70 to PtdIns(3,4,5)P3
[19].
20 mg of DNA was introduced into about 3610
6 cells by
electroporation using Cell Porator (Bethesda Research Laborato-
ries, Bethesda, MD) at 225 V with 800 mF capacitance. The stable
transformants were established by selection of the cells with
10 mg/ml hygromycin (Wako Co. Ltd., Tokyo). SWAP-70-374-2
and SWAP-70-374-24 cells were obtained as SWAP-70-374
protein-expressing cells and SWAP-70-374m1-12 and SWAP-70-
374m1-14 cells as SWAP-70-374m1-expressing cells.
Antibodies and Western blotting
Anti-SWAP-70 antibody was raised against bacterially ex-
pressed full-length human SWAP-70 fused to glutathione-S
transferase as described before [3]. This antibody does not
recognize mouse SWAP-70 but does recognize human SWAP-70.
Anti-ERK1/2 and anti-phospho-ERK1/2 antibodies were pur-
chased from Cell Signaling Technology Inc. (Danvers, MA). Anti-
b-actin antibody was from Sigma-Aldrich (St. Louis, MO).
Western blotting was done as described before [3]. Briefly,
blocking was done with 1% skim milk, and the protein was
visualized by the ECL system.
Determination of cell growth
Cells were plated on the 6-cm dishes at a density of 1610
5 cells
per dish and maintained with medium change every other day.
The numbers of the cells per dish were counted. For examination
of cell survival, cells were plated at a density of 2610
5 cells per 6-
cm dish and maintained without medium change. The cell
numbers shown in the figures are the means of three independent
experiments. Sanguinarine was purchased from Extrasynthese
(Genay Cedex, France), PD98059 and U0126 were from Wako
Co Ltd.
F-actin cosedimentation assay
Binding of SWAP-70 WT/374 to F-actin was tested as
described before [7]. Briefly, human non-muscle actin (Cytoskel-
eton Inc., Denver, CO) was polymerized in F-buffer (50 mM KCl,
2 mM MgCl2, 0.2 mM ATP, and 0.2 mM DTT in 2 mM
imidazole, pH 7.1) at room temperature for 30 min and incubated
with purified recombinant wild-type His-SWAP-70 or His-SWAP-
70-374 for 1 hr at room temperature. After ultracentrifugation at
109,0006g for 30 min at 25uC, the proteins in the supernatant or
the pellet were analyzed by SDS-PAGE, which was followed by
Coomassie Blue staining. The amount of SWAP-70 in each lane
was quantified by densitometric analysis using ImageJ 1.43 u
(National Institutes of Health, USA). The ratio of amount of
SWAP-70 in the pellet to that in the supernatant was calculated in
each sample. Then the value of the sample with F-actin was
normalized to that of the sample without F-actin. The results show
the relative amount of SWAP-70 specifically bound to F-actin.
The numerical formula to obtain the results is: (Relative affinity)
= {(amount of SWAP-70 in the pellet in the experiment with F-
actin)/(amount of SWAP70 in the supernatant in the experiment
with F-actin)}/{(amount of SWAP-70 in the pellet in the
experiment without F-actin)/(amount of SWAP70 in the super-
natant in the experiment without F-actin)}.
Confocal microscopy
Cells were fixed with 3.7% formaldehyde for 5 min at room
temperature. After permeabilization of the cells with PBS
containing 0.1% Triton for 5 min, F-actin was stained with
TRITC-phalloidin (Sigma-Aldrich). Cells were analyzed using a
confocal fluorescence microscope (Fluoview 300, Olympus,
Tokyo).
PtdIns(3,4,5)P3 analogue bead-binding assay
Proteins in 293T cells transfected with expression vectors for the
wild-type and the mutant SWAP-70s fused with GFP were
extracted by freezing-thawing three times in phosphate-buffered
saline (PBS) containing 1 mM EDTA, and 1 mM PMSF. After
removal of cell debris by ultracentrifugation (100,0006g, 30 min),
the samples were mixed with PtdIns(3,4,5)P3 analogue beads.
SWAP-70 Transforms MEFs
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buffer and analyzed by Western blotting with anti-GFP antibody.
Soft agar colony formation assay
1610
5 cells were suspended in 2 ml of a medium containing
0.2% agarose and plated onto a basal agarose layer consisting of a
medium containing 0.5% agarose in 6-cm dishes and incubated
for 2 weeks. 2 ml of a medium containing 0.2% agarose was added
onto the culture every week.
Serum requirement for the cell growth
Cells were plated at a density of 5610
4 cells per 6-cm dish and
cultured for 4 days in the medium containing low serum with a
medium change on day 2. Growth of the cells were observed
under the microscope.
Results
SWAP-70-374 localizes at the plasma membrane
We introduced various mutations in SWAP-70 to find out
interesting mutants. Especially, charged amino acids were targeted
because they might affect the conformation of the protein. Among
them, the 374 (K374A/K375A) mutation, which resides just
downstream of the central PH domain, showed an interesting
phenotype. This mutation did not affect the PtdIns(3,4,5)P3
binding activity of the protein (Fig. 1A). Cellular localization of
the protein was examined using green fluorescence protein (GFP)
as a marker. Cos7 cells were transfected with the expression
vectors for wild-type and mutant SWAP-70s fused to GFP. When
the proteins are in the cytosol, the signals of GFP get gradually
stronger toward the nuclei and the nuclei look almost transparent.
In contrast, when the proteins are located at the plasma
membrane, the strength of the signals is even and the nuclei look
turbid. By these criteria, localization of SWAP-70s was observed
under the microscope (Fig. 1B). The wild-type SWAP-70 was
found mostly in the cytosol in unstimulated cells: but it moved to
the plasma membrane and accumulated at the membrane ruffles
after stimulation with EGF as described before (Fig. 1B). In
contrast, a mutant, SWAP-70-374, was found at the plasma
membrane in most of the cells even when cells were not treated
with EGF (Fig. 1B). The protein moved to the membrane ruffles
after stimulation with EGF, suggesting that this mutant protein is
functional (Fig. 1B). The percentages of the cells with SWAP-70
located at the plasma membrane are shown in Fig 1C. This was
confirmed by examining the X-Z image of the cells. As shown in
Fig. 1D, wild-type protein found in the cytosol in unstimulated
Figure 1. A mutant SWAP-70, SWAP-70-374, locates at the plasma membrane. A, Binding activities of the mutant SWAP-70s to
PtdIns(3,4,5)P3 were analyzed using the bead binding assay. The upper panel shows SWAP-70s bound to the beads and the lower panel shows the
protein used for the assay. B, Expression vectors for the wild-type while the mutant SWAP-70 were introduced into Cos7 cells and the localization of
expressed proteins was analyzed by confocal microscopy. The stacked images are shown. The arrows indicate the cells whose SWAP-70 were found at
the plasma membrane. C, The percentages of the cells whose GFP-SWAP-70s were found at the plasma membrane are shown. Experiments were
repeated three times and the means are shown in the graph. The error bars show standard deviation. D, Expression vectors for GFP-SWAP-70 or GFP-
SWAP-70-374 were introduced into Cos7 cells by eletroporation. The cells expressing GFP-SWAP-70 were stimulated with EGF (100 ng/ml) for 5 min.
After fixation with formaldehyde, cells were stained with TRITC-phalloidin and observed using confocal microscopy. The upper panels show XY
images of the cells and the lower XZ images. The lines in the top panels show the place where XZ images were made.
doi:10.1371/journal.pone.0014180.g001
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mutant, 374, also localized at the plasma membrane even without
EGF-stimulation. It should be noted that this mutant co-localized
with F-actin.
Biochemical properties of SWAP-70-374
Because SWAP-70-374 co-localized with F-actin, its binding
activity to F-actin was analyzed. As shown previously, SWAP-70
exhibits actin binding ability in a co-sedimentation assay with F-
actin only when the C-terminal portion containing actin binding
domain was used. In contrast, full-length SWAP-70 does not
exhibit this ability [7]. Considering the fact that SWAP-70 co-
localizes with F-actin only when the cells are stimulated, these
results suggest that the actin binding domain of full-length SWAP-
70 may be masked and may be exposed only when activated.
Because SWAP-70-374 co-localizes with F-actin under unstimu-
lated conditions, we asked whether SWAP-70-374 bound to F-
actin in its full-length form in vitro. The co-sedimentation assay was
performed with non-muscle F-actin using two purified recombi-
nant proteins: His-SWAP-70-WT and 374. As shown in Fig. 2A, a
considerable amount of His-SWAP-70-374 co-sedimented with F-
actin, whereas only very small amount of His-SWAP-70-WT co-
sedimented. To quantify the difference between the F-actin
binding ability of the two proteins, the intensity of the bands of
SWAP-70s was measured and the scores that indicate relative
affinity of the proteins to F-actin were calculated (Fig. 2B). His-
SWAP-70-374 showed much higher affinity to F-actin than His-
SWAP-70-WT. The small amount of His-SWAP-70-WT co-
sedimented with F-actin could be attributed to the nonspecific
binding with F-actin through PH domain as previously reported
[7]. These results suggest that SWAP-70-374 may take the
activated conformation capable of binding to F-actin.
Elements required for translocation of SWAP-70-374 to
the membrane
How SWAP-70-374 localized at the plasma membrane was
examined using the mutants containing additional mutations. As
shown in Fig. 3, SWAP-70-374 was found at the plasma
membrane in most of the cells as mentioned above. Because
translocation of SWAP-70 to the plasma membrane after growth
Figure 2. F-actin co-sedimentation assay of SWAP-70s. A, F-actin
binding activity of SWAP-70s was examined. His-SWAP-70 (WT) or His-
SWAP-70-374 (374) was mixed with (+) or without (2)2 0 mM
polymerized non-muscle actin. After incubation for 1 hr, samples were
ultracentrifuged. Proteins in the supernatant (S) and the pellet (P) were
analyzed by SDS-PAGE followed by CBB staining. The faint bands seen
at the position of actin in the lane of actin (2) are the degradation
product of His-SWAP-70-WT/374. B, The same experiments as in A were
done for five times and the amount of SWAP-70 in each lane was
quantified. Relative affinity of SWAP-70s to F-actin were calculated as
described in Materials and Methods. Results from five independent
experiments are presented as the means. The error bars indicate
standard deviation (* P,0.02; t-test).
doi:10.1371/journal.pone.0014180.g002
Figure 3. Localization of mutant SWAP70s. Expression vectors for
GFP-SWAP-70, GFP-SWAP-70-374, GFP-SWAP-70-374m1, and GFP-
SWAP-70 (1-564) were introduced into Cos7 cells by eletroporation.
The cells expressing GFP-SWAP-70 were stimulated with EGF (100 ng/
ml) for 5 min. After fixation with formaldehyde, cells were stained with
TRITC-phalloidin and observed under the confocal microscope. The
upper panels show XY images of the cells, while the lower panels show
XZ images. The lines in the top panels show the position where XZ
images were made.
doi:10.1371/journal.pone.0014180.g003
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through its PH domain [19], dependence of localization on the PH
domain- PtdIns(3,4,5)P3 interaction was examined using a mutant
SWAP-70-374m1 carrying an additional mutation in the PH
domain, which abolishes the PtdIns(3,4,5)P3 binding activity
(Fig. 1A). SWAP-70-374m1 was still found at the plasma
membrane, suggesting that the binding activity to PtdIns(3,4,5)P3
was not required for translocation of the protein carrying the 374
mutation. In contrast, the SWAP-70-374 (1-564) protein, which
lacked the F-actin binding domain at the very carboxyl-terminal
region [7], failed to translocate to the plasma membrane,
suggesting that the F-actin binding activity was driving the protein
to the plasma membrane. These observations were reproducibly
seen in all of the cells expressing the SWAP-70 mutants.
Morphologic transformation of MEFs by expression of
the mutant SWAP-70
Because SWAP-70 is required for full transformation of MEFs
by the v-Src oncogene [3], it is possible that activated SWAP-70
can contribute to transformation of MEF 18-2. To examine this
possibility, the mutant protein, SWAP-70-374, was expressed in
MEFs. SWAP-70-374m1 was also used.
Expression vectors for the SWAP-70s were introduced in the
MEFs by electroporation and the stable transformants were
selected by hygromycin. As shown in Fig. 4A, MEF clones
expressing mutant SWAP-70s were obtained. When cells were
plated in a low density, morphology of the cells expressing SWAP-
70-374 was shorter and thicker than that of the wild-type cells,
suggesting that expression of SWAP-70-374 weakens the ability of
the cells to attach to the substratum as is the case with
transformation by the src oncogene (Fig. 4B) [3]. In contrast, cells
expressing SWAP-70-374m1 were flatter than the wild-type cells,
suggesting that they are strongly attached to the substratum
(Fig. 4B).
Expression of SWAP-70 mutants affect the cell growth
Cell growth of the transformants was monitored. MEFs
expressing SWAP-70-374 grew faster than the parental cells or
the cells expressing wild-type SWAP-70 (Fig. 5A and B). The
growth curve differed from time to time depending on the slight
difference in the numbers of the cells plated on the cells, reflecting
the delicate nature of the cell lines. However, in any case, growth
rates of SWAP-70-374-expressing cells were higher than those of
control cells. Also, saturation density of the cells was much higher
in the cells expressing SWAP-70-374 (compare Fig. 5A and B).
Although the growth rate of the cells was greatly enhanced and it
appeared that cell number would increase without limit, these cells
never piled up but rather formed a dense monolayer, unlike many
other transformed cells, such as Src-transformed MEFs. In
contrast, those expressing SWAP-70-374m1 grew more slowly
than the parental cells with low saturation density (compare Fig. 5
A and C). These results agree with the fact that cells were flatter
than the parental ones and suggest that SWAP-70-374m1 has an
inhibitory effect on cell growth.
Whether expression of SWAP-70-374 induces oncogenic
transformation was also tested by the soft agar colony formation
assay. As shown in Fig. 5D, the SWAP-70-374-expressing cells
formed colonies in soft agar, whereas parental cells did not.
Many of the malignant transformants can grow under the low-
serum conditions. This was also tested. As shown in Fig. 5E, when
the serum concentration was decreased to 0.5%, parental cells did
not grow. In contrast, the growth of the SWAP-70-374-expressing
cells was not affected. Growth rate in the medium containing 0.5%
serum was about 80% of that in the medium containing 5%
serum. These results suggest that SWAP-70-374 can induce
malignant transformation. The focus formation did not give clear
results. Because SWAP-70-374-transformed cells grow in mono-
layer, it was very hard to detect the foci. The SWAP-70-374-
transformed cells just pushed other cells to expand their area (data
not shown).
As shown in Fig. 4A, the expression levels of the exogenous
SWAP-70 were always low in SWAP-70-374 and relatively higher
in SWAP-70-374m1. The reason for this is not known. The low
expression of SWAP-70-374 could be due to its toxicity or its
instability.
MEFs expressing SWAP-70-374 are sensitive to nutrient
starvation
Generally, transformed cells grow faster than the normal cells,
pile up and do not exhibit contact inhibition. Therefore, whether
MEFs expressing SWAP-70-374 show contact inhibition and
resistance to nutrient starvation was tested. The transformants
were cultured without medium change for 2 weeks. During the
cultivation, parental and wild-type SWAP-70-expressing MEFs
reached confluence and survived more than one week (Fig. 6A and
D). In contrast, those expressing SWAP-70-374 grew faster but
when nutrients were used up, they died quickly (Fig. 6B, E, F).
These results suggest that MEFs expressing SWAP-70-374 are not
able to stop growing by contact inhibition and lose resistance to
nutrient starvation. Those expressing SWAP-70-374m1 survived
under the condition of nutrient starvation (Fig. 6C). Therefore,
expression of SWAP-70-374 gives some characteristics of cell
transformation to MEFs.
Sanguinarine inhibits overgrowth of SWAP-70-374-
transformed cells as well as membrane ruffling induced
by stimulation with EGF
To understand how SWAP-70-374 transforms MEFs, drugs that
inhibit overgrowth of SWAP-70-374-transformed cells under
nutrient starvation conditions were screened. Among 300 drugs
that include inhibitors for signaling molecules, proteins required
for secretion systems, and various kinases, 5 drugs exhibited such
an effect. To find which of these drugs target SWAP-70 itself or
something very closely related to the SWAP-70 pathway, another
assay was performed with these drugs. It has been shown that
SWAP-70 is required for membrane ruffling induced by EGF,
which is inhibited by wortmannin, a PtdIns-3 kinase inhibitor
(Fig. 7A). The selected drugs were added to this system. Only
sanguinarine inhibited membrane ruffling of Cos7 cells induced by
EGF stimulation (Fig. 7A). Therefore sanguinarine inhibits two
functions of SWAP-70, which is membrane ruffling and cell
transformation. These results suggest that this drug targets SWAP-
70 itself or another factor which is closely related to the SWAP-70
pathway. Sanguinarine greatly inhibited growth rate of SWAP-70-
374-transformed cells by sanguinarine but not that of parental
MEFs (Fig. 7B). These results support the idea that sanguinarine
blocks the SWAP-70-related signaling pathway.
ERK1/2 is activated in SWAP-70-374-transformed cells
To see what signaling pathway is involved in transformation of
MEFs by SWAP-70-374, activation of ERK1/2, which was often
seen in transformed cells, was examined. As shown in Fig. 8A,
ERK1/2 was activated in SWAP-70-374-transformed cells. In
contrast, this was not observed in non-transformed cells.
Therefore, the effect of MEK inhibitors on growth of SWAP-
70-374-transformed cells was examined. As shown in Fig. 8B, the
MEK inhibitors, PD98059 and U0126, blocked death of SWAP-
SWAP-70 Transforms MEFs
PLoS ONE | www.plosone.org 5 December 2010 | Volume 5 | Issue 12 | e14180Figure 4. Morphologic transformation of MEFs expressing exogenous SWAP-70. A, Western blotting analysis of the exogenously
expressed SWAP-70. Western blotting of SWAP-70 was done using cell lysate from each line (30 mg protein) (upper panel). b-actin was also detected
as a control (lower panel). B, Cell morphology of MEFs expressing exogenous SWAP-70s. Cells were plated at a density of 3610
5 cells in 6-cm dishes.
After cultivation for 1 day, cell morphology was observed under the microscope.
doi:10.1371/journal.pone.0014180.g004
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case with sanguinarine (Fig. 8B). In contrast, the growth rate of
these cells treated with the MEK inhibitors remained unchanged
until they reached confluence (Fig. 8C). This was true with the
parental cell line (Fig. 8C). However, these drugs caused contact
inhibition of SWAP-70-374-transformed cells, even though
saturation density was higher than that of parental cell lines
(Fig. 8B and C). Figure 8D shows that the MEK pathway was
indeed inhibited by these inhibitors. These results suggest that
activation of the ERK1/2 pathway partially contributes to
transformation of MEFs by SWAP-70-374.
Discussion
It has been shown that SWAP-70 is closely related to
malignancy of cancer. Overexpression of SWAP-70 has been
often seen in malignant tumor and in various tumor cell lines [1,2].
In this paper, we demonstrate that a mutant of SWAP-70, SWAP-
70-374, can morphologically transform, enhance cell growth, and
abolish the ability to stop growing by contact inhibition including
resistance to nutrient starvation in MEF cells. SWAP-70-374 may
be a constitutively activated mutant. SWAP-70-374 was capable of
binding to F-actin in vitro, whereas the wild-type protein was not.
Corresponding to this finding, SWAP-70-374 co-localized with F-
actin at the plasma membrane constitutively, when the wild-type
protein did so only when cells were stimulated with growth factors.
SWAP-70-374 is likely to take a conformation similar to the
activated form of SWAP-70. The finding that SWAP-70-374 can
still translocate to membrane ruffles after growth factor stimulation
suggests that the conformation of SWAP-70-374 may not be
abnormal (Fig. 1B). ERK1/2 was found to be activated in SWAP-
70-374 expressing cells, suggesting that SWAP-70-374 can activate
some signaling pathways.
The localization of SWAP-70-374 to the plasma membrane was
dependent on the F-actin binding activity. The PtdIns(3,4,5)P3
binding activity may not be required for this translocation because
an additional mutation that should abolish the PtdIns(3,4,5)P3
binding activity did not alter the membrane localization of the
protein. It has been shown that translocation of the wild-type
protein to the plasma membrane from the cytosol requires the
PtdIns(3,4,5)P3 binding activity of the protein. Therefore, the
mechanism of membrane localization of SWAP-70-374 may be
different from that of the wild-type protein stimulated with growth
factors. These results suggest that SWAP-70-374 forms a unique
complex that produces signals for abnormal growth of the cells.
Although the PtdIns(3,4,5)P3 binding activity was not required for
Figure 5. Growth of MEFs expressing exogenous SWAP-70s. Cells were plated at a density of 1610
5 cells in 6-cm dishes. A–C, Numbers of
cells in each dish were counted. Medium was replaced every other day. A, parental MEFs (closed circles) and MEFs expressing wild-type SWAP-70,
SWAP-70-5, (open circles) are shown. B, MEFs expressing SWAP-70-374: SWAP-70-374-2 (closed triangles) and SWAP-70-374-24 (open triangles). C,
MEFs expressing SWAP-70-374m1: SWAP-70-374m1-12 (closed squares) and SWAP-70-374m1-14 (open squares). The standard deviations for each
point were less than 4%. D, Soft agar colony formation assay was performed as described in Materials and Methods. After cultivation for 18days, the
colonies were observed under the microscope. E, Cells were plated at a density of 5610
4 cells per 6-cm dish in the medium containing 5% or 0.5%
fetal bovine serum. Images of the cells after cultivation for 2 or 4 days are shown. As shown in the figure, parental cell line did not grow in the
medium containing 0.5% fetal bovine serum, whereas growth of SWAP-70-374-2 and SWAP-70-374-24 was not greatly affected.
doi:10.1371/journal.pone.0014180.g005
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the PtdIns(3,4,5)P3 binding activity appears to be still required for
transformation of MEFs. Interestingly, SWAP-70-374m1, which is
incapable of binding to PtdIns(3,4,5)P3, inhibited growth of MEFs.
Expression of this protein slows down the growth of the cells and
makes them flatter than the parental cells. Saturation cell density
was also lower than that of the parental cells. It is likely that
SWAP-70-374m1 may be in an activated conformation that can
Figure 6. Tolerance of MEFs expressing exogenous SWAP-70s to nutrient starvation. Cells were cultured at a density of 2610
5 cells in 6-
cm dishes and cultured without medium replacement. A–C, Numbers in each dish were counted. D–F, Photographs of the cells when nutrient
starved. A, parental MEFs (closed circles) and MEFs expressing wild-type SWAP-70, SWAP-70-5, (open circles) are shown. B, MEFs expressing SWAP-70-
374: SWAP-70-374-2 (closed triangles) and SWAP-70-374-24 (open triangles). C, MEFs expressing SWAP-70-374m1: SWAP-70-374m1-12 (closed
squares) and SWAP-70-374m1-14 (open squares). The standard deviations for each point were less than 4%. D, SWAP-70-5 after cultivation for 7 days.
E, SWAP-70-374-2 after cultivation of 5 days. F, SWAP-70-374-24 after cultivation for 7 days. Error bars indicate standard deviation.
doi:10.1371/journal.pone.0014180.g006
Figure 7. Sanguinarine inhibits membrane ruffling of Cos7 cells. A, Cos7 cells were treated with sanguinarine (2 mM) or wortmannin
(100 nM) 15 min prior to EGF (100 ng/ml) stimulation for 5 min. After fixation with formaldehyde, cells were observed. The arrows indicate
membrane ruffles. B, 18-2 cells or SWAP-70-374-2 cells were seeded on 6-cm dishes at a cell density of 1610
5 cells in the dish. Cells were grown in the
presence or absence of sanguinarine (0.8 mM) with medium change on every other day. Cell numbers were monitored. Open circles: SWAP-70-374-2
cells without sanguinarine; closed circles: 18-2 cells without sanguinarine; open triangles: SWAP-70-374-2 cells with sanguinarine, closed triangles: 18-
2 cells with sanguinarine. Error bars indicate standard deviation.
doi:10.1371/journal.pone.0014180.g007
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of SWAP-70-374m1’s inability to bind to PtdIns(3,4,5)P3, the
signal may be stopped at SWAP-70-374m1 level.
Sanguinarine has been shown to exhibit anti-tumor activity. It
has been shown that sanguinarine induces apoptosis on various
tumor cell lines [10,11,12,13,14]. It has been suggested that
sanguinarine interacts with chromatin to modulate transcription
[16]. In this paper, sanguinarine was found to inhibit transforma-
tion of MEFs by SWAP-70-374. Only SWAP-70-374-dependent
acceleration of growth rate was inhibited by sanguinarine. Growth
rate of 18-2 was not affected by sanguinarine. This can be
explained as follows. SWAP-70-374 may activate not only the
ERK1/2 pathway but also some other signaling pathways. One of
the unknown pathways may be responsible for acceleration of the
growth rate (Fig. 9). This unknown pathway may not be activated
in 18-2 cells. In such a case, sanguinarine cannot inhibit growth of
18-2 cells but can inhibit that of SWAP-70-374-transformed cells
(Fig. 7B). Unlike sanguinarine, MEK inhibitors did not slow down
the growth of SWAP-70-374-transformed cells (Fig. 8C). However,
MEK inhibitors caused restoration of contact inhibition of these
cells (Fig. 8C). These results suggest that the ERK1/2 pathway
regulates only contact inhibition of these cells and that there may
be at least one other pathway that stimulates cell growth (Fig. 9).
Characteristics of MEFs may differ from lines to lines. Whether
the regulation of contact inhibition by the ERK1/2 pathway is
common to all the MEF lines should be tested in the future.
Figure 8. Effect of sanguinarine and MEK inhibitors on growth
of SWAP-70-374-transformed cells. A, A confluent culture of 18-2
and SWAP-70-374-2 cells were replated to fresh dishes and cultured for
1day in the presence or absence of sanguinarine (0.8 mM). The cells
were lysed and analyzed for phosphorylation of ERK1/2. Left half,
probed with an anti-phospho-ERK1/2 antibody. Right half, probed with
an anti-ERK1/2 antibody. B, SWAP-70-374-2 cells (2610
5 cells/6-cm dish)
Figure 9. A model for signaling of SWAP-70-374-dependent
transformation of MEFs. The putative signaling model of SWAP-70-
374-dependent transformation is shown. So far, only the role of the
ERK1/2 pathway in regulation of contact inhibition is known: there
should be at least one more signaling pathway responsible for fast
growth of the cells.
doi:10.1371/journal.pone.0014180.g009
were cultured in the absence or presence of sanguinarine (0.8 mM),
PD98059 (10 mM), or U0126 (10 mM) without medium change for 7 days.
In the absence of the drugs, the cells died whereas they survived in the
presence of these drugs. C, 18-2 cells or SWAP-70-374-2 cells were
seeded at a cell density of 2610
5cells per 6-cm dish. Cells were grown in
the presence or absence of PD98059 (10 mM) or U0126 (10 mM) with
medium change on every other day. Open circles, SWAP-70-374-2 cells
without drugs; open triangles, SWAP-70-374-2 cells with PD98059; open
squares, SWAP-70-374-2 cells with U0126; closed circles, 18-2 cells
without drugs; closed triangles, 18-2 cells with PD98059; closed squares,
18-2 cells with U0126. Error bars indicate standard deviation. D,
Confluent cultures of SWAP-70-374-2 cells were replated to fresh dishes
and cultured for 1day in the presence or absence of PD98059 (10 mM)
or U0126 (10 mM). The cells were lysed and analyzed for phosphory-
lation of ERK1/2. Left half, probed with an anti-phospho-ERK1/2
antibody. Right half, probed with an anti-ERK1/2 antibody.
doi:10.1371/journal.pone.0014180.g008
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PLoS ONE | www.plosone.org 9 December 2010 | Volume 5 | Issue 12 | e14180Sanguinarine also inhibited membrane ruffling of Cos7 cells
after growth factor treatment, which is another function of SWAP-
70. Therefore, it is possible that this drug may inhibit SWAP-70-
mediated signaling pathways. In addition to sanguinarine’s role in
the nucleus, our new finding may supply information important
for understanding of the function of sanguinarine. It should be
noted that the concentration of sanguinarine required for
inhibiting SWAP-70-374-induced transformation was much lower
than that required for inhibition of chromatin related reactions.
Because PtdIns(3,4,5)P3 binding activity of the SWAP-70
mutant is required for transformation of MEFs, it is likely that
the PtdIns 3-kinase pathway is also involved in the transformation
of MEFs by the mutant SWAP-70. However, which signaling
pathways other than the ERK1/2 pathway are required for cell
transformation are not known. Further examination may be
required to understand the whole picture of signaling pathways
activated by the SWAP-70-374-F-actin complex.
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